The competitive rower-turned-researcher spoke to Spectrum about how trying out for the U.S. national rowing team and a subsequent coaching position shaped her study of speech development.

A meeting in Texas reckons with the future of treatment, following two setbacks in 2020.

The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.

Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.

The field of ABA needs more compassion and individualization.

Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.

Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Most autistic children in the Netherlands have used some sort of treatment, but the number, type and timing varies depending on considerations unrelated to their condition.

When the federal public health emergency expires, so too could temporary insurance coverage of applied behavior analysis conducted remotely. A proposed rule could block those changes, however, at least for people with public insurance.

A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.